AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 103 filers reported holding AVROBIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $28,000 | -84.2% | 20,842 | -54.7% | 0.00% | – |
| Q4 2021 | $177,000 | -16.9% | 46,007 | +20.4% | 0.00% | – |
| Q3 2021 | $213,000 | -52.2% | 38,212 | -23.9% | 0.00% | – |
| Q2 2021 | $446,000 | -34.9% | 50,202 | -6.9% | 0.00% | – |
| Q1 2021 | $685,000 | +6.2% | 53,949 | +16.7% | 0.00% | – |
| Q4 2020 | $645,000 | -61.6% | 46,246 | -64.2% | 0.00% | -100.0% |
| Q3 2020 | $1,681,000 | -48.7% | 129,137 | -31.3% | 0.00% | 0.0% |
| Q2 2020 | $3,278,000 | +34.5% | 187,874 | +20.0% | 0.00% | 0.0% |
| Q1 2020 | $2,437,000 | +30.2% | 156,531 | +68.3% | 0.00% | 0.0% |
| Q4 2019 | $1,872,000 | +85.7% | 92,985 | +30.2% | 0.00% | – |
| Q3 2019 | $1,008,000 | -8.2% | 71,417 | +5.7% | 0.00% | – |
| Q2 2019 | $1,098,000 | -5.6% | 67,547 | +28.1% | 0.00% | – |
| Q1 2019 | $1,163,000 | – | 52,737 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,191,676 | $16,612,000 | 8.00% |
| Aisling Capital Management LP | 1,009,779 | $14,076,000 | 2.42% |
| Burrage Capital Management LLC | 145,715 | $2,031,000 | 1.55% |
| Camber Capital Management LP | 3,133,333 | $43,679,000 | 1.53% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $4,399,000 | 1.02% |
| SPHERA FUNDS MANAGEMENT LTD. | 655,874 | $9,143,000 | 0.81% |
| EMERALD ADVISERS, LLC | 1,009,212 | $14,068,000 | 0.47% |
| Penn Mutual Asset Management, LLC | 37,306 | $520,000 | 0.46% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 932,627 | $13,001,000 | 0.45% |
| MPM BioImpact LLC | 364,285 | $5,078,000 | 0.44% |